9 METERS BIOPHARMA, INC. Quarterly Operating Income (Loss) in USD from Q2 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
9 Meters Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2015 to Q1 2023.
  • 9 Meters Biopharma, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$12.8M, a 12.5% decline year-over-year.
  • 9 Meters Biopharma, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$43.4M, a 1.67% decline year-over-year.
  • 9 Meters Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$42M, a 14.3% decline from 2021.
  • 9 Meters Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$36.8M, a 39.6% increase from 2020.
  • 9 Meters Biopharma, Inc. annual Operating Income (Loss) for 2020 was -$60.9M, a 138% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$43.4M -$12.8M -$1.42M -12.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$42M -$10.7M -$1.18M -12.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$40.8M -$8.72M +$4.82M +35.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$45.7M -$11.2M -$2.94M -35.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$42.7M -$11.4M -$5.97M -110% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$36.8M -$9.56M -$4.79M -100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$32M -$13.5M -$7.24M -115% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$24.7M -$8.26M +$36.6M +81.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$61.3M -$5.4M -$439K -8.86% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$60.9M -$4.78M +$12.5M +72.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$73.3M -$6.3M +$204K +3.13% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$73.5M -$44.8M -$38.7M -632% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$34.8M -$4.96M -$9.27M -215% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$25.5M -$17.2M -$21M -561% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$4.58M -$6.51M -$6.29M -2863% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.71M -$6.12M -$9.5M -281% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $11.2M $4.31M -$7.02M -61.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $18.2M $3.74M +$1.52M +68.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 $16.7M -$220K -$2.56M -109% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $19.3M $3.38M +$685K +25.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $18.6M $11.3M +$7.41M +189% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $11.2M $2.22M +$3.27M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $7.9M $2.34M +$4.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $3.19M $2.69M +$3.59M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$398K $3.92M +$5.55M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$5.94M -$1.05M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$2.36M -$972K -69.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$901K +$156K +14.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$1.63M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-19
Q3 2015 -$1.39M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-16
Q2 2015 -$1.06M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.